22 results on '"Rustin, Gordon"'
Search Results
2. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
3. Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer
4. Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors
5. Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment
6. Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide
7. Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)
8. Can We Now Agree to Use the Same Definition to Measure Response According to CA-125?
9. Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
10. Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)
11. Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging
12. Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results
13. Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials
14. Progress in the Management of Gynecologic Cancer: Consensus Summary Statement
15. Effects of 5,6-Dimethylxanthenone-4-Acetic Acid on Human Tumor Microcirculation Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
16. Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels
17. Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors [Ovarian Cancer]
18. Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials
19. Good manners for the pharmaceutical industry
20. Circulating tumor markers in gynecological tumors
21. Use of CA 125 in follow-up of ovarian cancer
22. Treatment of good-risk, stage II, non-seminomatous testis cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.